NCT06906822
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06906822
Title PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients (PlugIN)
Acronym PlugIN
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol Multidisciplinar de Melanoma
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Complexo Hospitalario Universitario de A Coruña A Coruña A Coruña 15006 Spain Details
Institut Català D'Oncologia - Badalona Badalona Barcelona 08916 Spain Details
Hospital Universitari Dexeus Barcelona Barcelona 08028 Spain Details
Hospital Universitario Valle de Hebrón Barcelona Barcelona 08035 Spain Details
Hospital Clinic de Barcelona Barcelona Barcelona 08036 Spain Details
Hospital Universitario Marqués de Valdecilla Santander Cantabria 39008 Spain Details
Hospital Universitario Ramón y Cajal Madrid Madrid 28034 Spain Details
Hospital Universitario 12 de Octubre Madrid Madrid 28041 Spain Details
Hospital Universitario La Paz Madrid Madrid 28046 Spain Details
Hospital Clínico Universitario Virgen de la Arrixaca Murcia Murcia 30120 Spain Details
Hospital Virgen del Rocío Seville Sevilla 41013 Spain Details
Hospital General de Valencia Valencia Valencia 46014 Spain Details
Hospital Universitario Miguel Servet Zaragoza Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field